Moreover, analysis of larger cohorts of SOT recipients developing tumors different from non-melanoma skin cancers is warranted to establish whether circulating TERT mRNA levels can serve as a global early marker of tumor development in this setting. Here, TERT is linked to non-melanoma skin carcinoma.